{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:56:49Z","timestamp":1792173409348,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1A6A1A03010528"],"award-info":[{"award-number":["2016R1A6A1A03010528"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1I1A1A01056316"],"award-info":[{"award-number":["2019R1I1A1A01056316"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2019R1A3A3005437"],"award-info":[{"award-number":["NRF-2019R1A3A3005437"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["IITP-2019-2011-1-00783"],"award-info":[{"award-number":["IITP-2019-2011-1-00783"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3A9C6032067"],"award-info":[{"award-number":["2017M3A9C6032067"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.actbio.2020.09.015","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:52:10Z","timestamp":1599825130000},"page":"174-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["3D printing of drug-loaded multi-shell rods for local delivery of bevacizumab and dexamethasone: A synergetic therapy for retinal vascular diseases"],"prefix":"10.1016","volume":"116","author":[{"given":"Jae Yon","family":"Won","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-2879","authenticated-orcid":false,"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Woo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2020.09.015_bib0001","series-title":"Mechanisms of Retinal and Choroidal Neovascularization","author":"D'Amore","year":"1994"},{"issue":"9827","key":"10.1016\/j.actbio.2020.09.015_bib0002","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2020.09.015_bib0003","unstructured":"National Eye Institute [Internet]. Bethesda (MD): national Institutes of Health (US); Age-Related Macular Degeneration (AMD) Tables; reviewed2013 July; cited 2019 May 07. Available from: https:\/\/nei.nih.gov\/eyedata\/amd\/tables."},{"key":"10.1016\/j.actbio.2020.09.015_bib0004","unstructured":"National Eye Institute [Internet]. Bethesda (MD): national Institutes of Health (US); Diabetic Retinopathy; reviewed2013 July; cited 2019 May 07. Available from: https:\/\/nei.nih.gov\/eyedata\/diabetic."},{"issue":"5","key":"10.1016\/j.actbio.2020.09.015_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1444-0938.2008.00305.x","article-title":"Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age\u2010related macular degeneration: a review of current practice","volume":"91","author":"Van Wijngaarden","year":"2008","journal-title":"Clin. Exp. Optom."},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0006","first-page":"331","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin\u00ae) for neovascular age-related macular degeneration, Ophthalmic Surgery","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Lasers Imaging Retin."},{"issue":"10","key":"10.1016\/j.actbio.2020.09.015_bib0007","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul. Surf."},{"issue":"13","key":"10.1016\/j.actbio.2020.09.015_bib0009","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.actbio.2020.09.015_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","article-title":"Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics","volume":"29","author":"Laude","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"10.1016\/j.actbio.2020.09.015_bib0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.actbio.2020.09.015_bib0012","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00417-005-1182-1","article-title":"Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis","volume":"243","author":"Gan","year":"2005","journal-title":"Graefe\u2019s Archive Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0013","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","article-title":"Complications in patients after intravitreal injection of bevacizumab","volume":"86","author":"Shima","year":"2008","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.actbio.2020.09.015_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"11","key":"10.1016\/j.actbio.2020.09.015_bib0015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","article-title":"Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration","volume":"115","author":"Wickremasinghe","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0017","doi-asserted-by":"crossref","first-page":"96","DOI":"10.21276\/apjhs.2018.5.2.19","article-title":"Hydrogels in ophthalmic drug delivery system-A mini","volume":"5","author":"Anjali","year":"2018","journal-title":"Asian Pac. J. Health Sci."},{"issue":"3\u20134","key":"10.1016\/j.actbio.2020.09.015_bib0018","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"Del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.actbio.2020.09.015_bib0019","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0020","first-page":"317","article-title":"Sustained release intraocular drug delivery devices for treatment of uveitis","volume":"6","author":"Haghjou","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"3","key":"10.1016\/j.actbio.2020.09.015_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and chronic inflammation: cause or consequence?","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis"},{"issue":"15","key":"10.1016\/j.actbio.2020.09.015_bib0022","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1167\/iovs.16-19754","article-title":"The antiangiogenic effects of gold nanoparticles on experimental choroidal neovascularization in mice","volume":"57","author":"Roh","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2020.09.015_bib0023","first-page":"345","article-title":"Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity","volume":"14","author":"Geisen","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.actbio.2020.09.015_bib0024","first-page":"3566","article-title":"Retro-orbital injection of FITC-dextran is an effective and economical method for observing mouse retinal vessels","volume":"17","author":"Li","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.actbio.2020.09.015_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ab.2018.06.003","article-title":"Secondary structure assessment of formulated bevacizumab in the presence of SDS by deep ultraviolet resonance Raman (DUVRR) spectroscopy","volume":"555","author":"Qiu","year":"2018","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0026","article-title":"Polymer biodegradation and biodegradable polymers-a review","volume":"19","author":"Leja","year":"2010","journal-title":"Pol. J. Environ. Stud."},{"key":"10.1016\/j.actbio.2020.09.015_bib0027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejps.2017.05.019","article-title":"Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses","volume":"105","author":"Sousa","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2020.09.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/780634","article-title":"Drug delivery implants in the treatment of vitreous inflammation","author":"Wang","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.actbio.2020.09.015_bib0029","series-title":"Update on Intravitreal Injections: Euretina Expert Consensus Recommendations","author":"Grzybowski","year":"2018"},{"key":"10.1016\/j.actbio.2020.09.015_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2016.06.015","article-title":"A 3D-printed local drug delivery patch for pancreatic cancer growth suppression","volume":"238","author":"Yi","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2020.09.015_bib0031","unstructured":"H. Dehnad, K. Kleine, P. Kramer, J. Carlson, Porous metal for drug-loaded stents, Google Patents, 2004."},{"issue":"1","key":"10.1016\/j.actbio.2020.09.015_bib0032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.foodhyd.2012.04.006","article-title":"Rheological investigation of alginate chain interactions induced by concentrating calcium cations","volume":"30","author":"Yang","year":"2013","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.actbio.2020.09.015_bib0033","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcis.2019.07.082","article-title":"Extended release of dexamethasone from oleogel based rods","volume":"555","author":"Macoon","year":"2019","journal-title":"J. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0034","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","article-title":"Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro","volume":"7","author":"Wang","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.actbio.2020.09.015_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2016.03.035","article-title":"Targeted delivery of low-dose dexamethasone using PCL\u2013PEG micelles for effective treatment of rheumatoid arthritis","volume":"230","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.actbio.2020.09.015_bib0036","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1167\/iovs.12-9702","article-title":"Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade","volume":"53","author":"Xu","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0037","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","article-title":"Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection","volume":"110","author":"Kwak","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"11","key":"10.1016\/j.actbio.2020.09.015_bib0038","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.actbio.2020.09.015_bib0039","series-title":"Proceedings of the National Academy of Sciences","first-page":"21264","article-title":"Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis","volume":"106","author":"Schonthaler","year":"2009"},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jbm.a.30294","article-title":"Fabrication, implantation, elution, and retrieval of a steroid\u2010loaded polycaprolactone subretinal implant","volume":"73","author":"Beeley","year":"2005","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"10","key":"10.1016\/j.actbio.2020.09.015_bib0041","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.actbio.2020.09.015_bib0042","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nmat2309","article-title":"Drug delivery: the heart of the matter","volume":"7","author":"Putnam","year":"2008","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.actbio.2020.09.015_bib0043","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/erd.09.4","article-title":"Drug delivery systems for the eye","volume":"6","author":"Kearns","year":"2009","journal-title":"Expert Rev. Med. Devices"},{"issue":"9","key":"10.1016\/j.actbio.2020.09.015_bib0044","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.biomaterials.2005.09.019","article-title":"The in vivo degradation, absorption and excretion of PCL-based implant","volume":"27","author":"Sun","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2020.09.015_bib0045","series-title":"Scaffolds in Tissue Engineering Bone and Cartilage, The Biomaterials: Silver Jubilee Compendium","first-page":"175","author":"Hutmacher","year":"2000"},{"issue":"26","key":"10.1016\/j.actbio.2020.09.015_bib0046","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/j.biomaterials.2004.01.066","article-title":"The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis","volume":"25","author":"Sung","year":"2004","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2020.09.015_bib0047","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biomaterials.2008.10.006","article-title":"The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction","volume":"30","author":"Tillman","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2020.09.015_bib0048","series-title":"Electrospun Materials for Tissue Engineering and Biomedical Applications: Research, Design and Commercialization","author":"Uyar","year":"2017"},{"issue":"5\u20136","key":"10.1016\/j.actbio.2020.09.015_bib0049","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"33","key":"10.1016\/j.actbio.2020.09.015_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201700798","article-title":"Tissue engineered bio\u2010blood\u2010vessels constructed using a tissue\u2010specific bioink and 3D coaxial cell printing technique: a novel therapy for ischemic disease","volume":"27","author":"Gao","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0051","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/aos.12901","article-title":"Needle size in intravitreal injections\u2013pain evaluation of a randomized clinical trial","volume":"94","author":"Haas","year":"2016","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.actbio.2020.09.015_bib0052","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0420.2004.00336.x","article-title":"Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology","volume":"83","author":"S\u00f8rensen","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"issue":"10","key":"10.1016\/j.actbio.2020.09.015_bib0053","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.actbio.2020.09.015_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12348-011-0042-x","article-title":"Wandering ozurdex\u00ae implant","volume":"2","author":"Bansal","year":"2012","journal-title":"infection. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.actbio.2020.09.015_bib0055","first-page":"44","article-title":"Sustained-release corticosteroid delivery systems","author":"Kiss","year":"2010","journal-title":"Retin. Today"},{"issue":"1","key":"10.1016\/j.actbio.2020.09.015_bib0056","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1167\/iovs.13-13120","article-title":"Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo","volume":"55","author":"Rauck","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2020.09.015_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bm2009558","article-title":"Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel","volume":"13","author":"Wang","year":"2011","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.actbio.2020.09.015_bib0058","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0059","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0060","first-page":"897","article-title":"Systematic review on sterilization methods of implants and medical devices","volume":"8","author":"Govindaraj","year":"2015","journal-title":"Int. J. Chem.Tech. Res."},{"issue":"2","key":"10.1016\/j.actbio.2020.09.015_bib0061","first-page":"133","article-title":"A review: radiation sterilization of pharmaceuticals","volume":"26","author":"Jacobs","year":"1977","journal-title":"Radiat. Phys. Chem."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120305298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120305298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:33:38Z","timestamp":1761672818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706120305298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":61,"alternative-id":["S1742706120305298"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2020.09.015","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D printing of drug-loaded multi-shell rods for local delivery of bevacizumab and dexamethasone: A synergetic therapy for retinal vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2020.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}